2型糖尿病患者的疾病费用和相关因素:来自印度南部三级保健中心的调查结果

IF 3.4 3区 医学 Q1 HEALTH POLICY & SERVICES
Jeby Jose Olickal , Palanivel Chinnakali , BS Suryanarayana , Ganesh Kumar Saya , Kalaiselvan Ganapathy , DKS Subrahmanyam
{"title":"2型糖尿病患者的疾病费用和相关因素:来自印度南部三级保健中心的调查结果","authors":"Jeby Jose Olickal ,&nbsp;Palanivel Chinnakali ,&nbsp;BS Suryanarayana ,&nbsp;Ganesh Kumar Saya ,&nbsp;Kalaiselvan Ganapathy ,&nbsp;DKS Subrahmanyam","doi":"10.1016/j.hlpt.2023.100807","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>Our aim was to estimate the cost of illness (COI) from the patient's perspective among individuals with type 2 diabetes (PWDs) attending a public tertiary care center in southern India.</p></div><div><h3>Methods</h3><p>This cross-sectional analytical study included PWDs on treatment for at least one year. Interviews captured direct medical costs (hospitalization, tests, medications), direct non-medical costs (meals, travel), and indirect costs (wage loss). Median regression analyses examined factors associated with total COI.</p></div><div><h3>Results</h3><p>Of total 1002 PWDs included<strong>,</strong> the mean (SD) age was 56 (12) years. Majority were males and from rural areas. One-third had diabetes for more than ten years, half were on insulin therapy, and more than half had comorbidities. Median (IQR) reported household income was US$637 (US$318–US$1115)/year. The Median (IQR) annual COI was US$39 (US$20-US$67), of which 73% was direct costs with a median of US$28. Majority of the participants (<em>n</em>=818, 81.6%) spent on laboratory investigations as direct medical costs and travel (<em>n</em>=1000, 99.8%) as direct non-medical costs. Travel costs represented the largest share of total COI (41%), followed by wage loss. Median annual COI was higher for males, salaried PWDs, and PWDs on insulin.</p></div><div><h3>Conclusions</h3><p>Our findings highlight that PWDs attending a public tertiary care center bear significant out-of-pocket expenses for diabetes care, primarily due to direct costs. Particularly, travel costs were identified as the most substantial component of the total COI.</p></div>","PeriodicalId":48672,"journal":{"name":"Health Policy and Technology","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2023-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cost-of-illness and associated factors among persons with type 2 diabetes: Findings from a tertiary care center in South India\",\"authors\":\"Jeby Jose Olickal ,&nbsp;Palanivel Chinnakali ,&nbsp;BS Suryanarayana ,&nbsp;Ganesh Kumar Saya ,&nbsp;Kalaiselvan Ganapathy ,&nbsp;DKS Subrahmanyam\",\"doi\":\"10.1016/j.hlpt.2023.100807\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><p>Our aim was to estimate the cost of illness (COI) from the patient's perspective among individuals with type 2 diabetes (PWDs) attending a public tertiary care center in southern India.</p></div><div><h3>Methods</h3><p>This cross-sectional analytical study included PWDs on treatment for at least one year. Interviews captured direct medical costs (hospitalization, tests, medications), direct non-medical costs (meals, travel), and indirect costs (wage loss). Median regression analyses examined factors associated with total COI.</p></div><div><h3>Results</h3><p>Of total 1002 PWDs included<strong>,</strong> the mean (SD) age was 56 (12) years. Majority were males and from rural areas. One-third had diabetes for more than ten years, half were on insulin therapy, and more than half had comorbidities. Median (IQR) reported household income was US$637 (US$318–US$1115)/year. The Median (IQR) annual COI was US$39 (US$20-US$67), of which 73% was direct costs with a median of US$28. Majority of the participants (<em>n</em>=818, 81.6%) spent on laboratory investigations as direct medical costs and travel (<em>n</em>=1000, 99.8%) as direct non-medical costs. Travel costs represented the largest share of total COI (41%), followed by wage loss. Median annual COI was higher for males, salaried PWDs, and PWDs on insulin.</p></div><div><h3>Conclusions</h3><p>Our findings highlight that PWDs attending a public tertiary care center bear significant out-of-pocket expenses for diabetes care, primarily due to direct costs. Particularly, travel costs were identified as the most substantial component of the total COI.</p></div>\",\"PeriodicalId\":48672,\"journal\":{\"name\":\"Health Policy and Technology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2023-09-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Health Policy and Technology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2211883723000837\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEALTH POLICY & SERVICES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Policy and Technology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2211883723000837","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0

摘要

我们的目的是从患者的角度估计在印度南部一家公立三级医疗中心就诊的2型糖尿病(PWDs)患者的疾病成本(COI)。这项横断面分析研究包括治疗至少一年的残疾患者。访谈记录了直接医疗费用(住院、检查、药物)、直接非医疗费用(膳食、差旅费)和间接费用(工资损失)。中位数回归分析检查了与总COI相关的因素。共纳入1002名残疾患者,平均(SD)年龄为56(12)岁。大多数是男性,来自农村地区。三分之一的人患有糖尿病超过十年,一半的人正在接受胰岛素治疗,超过一半的人有合并症。报告的家庭收入中位数(IQR)为637美元/年(318 - 1115美元)。年度COI中位数(IQR)为39美元(20- 67美元),其中73%为直接成本,中位数为28美元。大多数参与者(n=818, 81.6%)将实验室调查作为直接医疗费用,将差旅费(n=1000, 99.8%)作为直接非医疗费用。差旅成本占总成本损失的比例最大(41%),其次是工资损失。男性、受薪残疾患者和接受胰岛素治疗的残疾患者的年COI中位数较高。我们的研究结果强调,在公立三级医疗中心接受糖尿病护理的残疾人士承担了大量的自付费用,主要是由于直接费用。特别是,旅费被确定为COI总额中最重要的组成部分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Cost-of-illness and associated factors among persons with type 2 diabetes: Findings from a tertiary care center in South India

Objective

Our aim was to estimate the cost of illness (COI) from the patient's perspective among individuals with type 2 diabetes (PWDs) attending a public tertiary care center in southern India.

Methods

This cross-sectional analytical study included PWDs on treatment for at least one year. Interviews captured direct medical costs (hospitalization, tests, medications), direct non-medical costs (meals, travel), and indirect costs (wage loss). Median regression analyses examined factors associated with total COI.

Results

Of total 1002 PWDs included, the mean (SD) age was 56 (12) years. Majority were males and from rural areas. One-third had diabetes for more than ten years, half were on insulin therapy, and more than half had comorbidities. Median (IQR) reported household income was US$637 (US$318–US$1115)/year. The Median (IQR) annual COI was US$39 (US$20-US$67), of which 73% was direct costs with a median of US$28. Majority of the participants (n=818, 81.6%) spent on laboratory investigations as direct medical costs and travel (n=1000, 99.8%) as direct non-medical costs. Travel costs represented the largest share of total COI (41%), followed by wage loss. Median annual COI was higher for males, salaried PWDs, and PWDs on insulin.

Conclusions

Our findings highlight that PWDs attending a public tertiary care center bear significant out-of-pocket expenses for diabetes care, primarily due to direct costs. Particularly, travel costs were identified as the most substantial component of the total COI.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Health Policy and Technology
Health Policy and Technology Medicine-Health Policy
CiteScore
9.20
自引率
3.30%
发文量
78
审稿时长
88 days
期刊介绍: Health Policy and Technology (HPT), is the official journal of the Fellowship of Postgraduate Medicine (FPM), a cross-disciplinary journal, which focuses on past, present and future health policy and the role of technology in clinical and non-clinical national and international health environments. HPT provides a further excellent way for the FPM to continue to make important national and international contributions to development of policy and practice within medicine and related disciplines. The aim of HPT is to publish relevant, timely and accessible articles and commentaries to support policy-makers, health professionals, health technology providers, patient groups and academia interested in health policy and technology. Topics covered by HPT will include: - Health technology, including drug discovery, diagnostics, medicines, devices, therapeutic delivery and eHealth systems - Cross-national comparisons on health policy using evidence-based approaches - National studies on health policy to determine the outcomes of technology-driven initiatives - Cross-border eHealth including health tourism - The digital divide in mobility, access and affordability of healthcare - Health technology assessment (HTA) methods and tools for evaluating the effectiveness of clinical and non-clinical health technologies - Health and eHealth indicators and benchmarks (measure/metrics) for understanding the adoption and diffusion of health technologies - Health and eHealth models and frameworks to support policy-makers and other stakeholders in decision-making - Stakeholder engagement with health technologies (clinical and patient/citizen buy-in) - Regulation and health economics
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信